Air Products & Chemicals vs Chemours
APD and CC side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APD and CC compare
Air Products & Chemicals is the larger company, worth 34 times as much as Chemours ($70.2B against $2.1B).
Air Products & Chemicals grew revenue faster over the last twelve months (4.5% versus 0.07% for Chemours).
Air Products & Chemicals keeps more of each dollar of sales as profit, with a net margin of −0.38% compared with −2.6% at Chemours.
Both pay dividends: Air Products & Chemicals yields 2.3% and Chemours 2.6%.
Air Products & Chemicals scores higher on the StockData Score (9 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APD | CC |
|---|---|---|
| Size and price | ||
| Market cap | $70.2B | $2.1B |
| Share price | $315.18 | $13.72 |
| Change, 1 year | 22.0% | 7.6% |
| Change, 5 years | 5.9% | −56.8% |
| Beta (5Y) | 0.71 | 1.57 |
| Employees | 21K | 5,700 |
| StockData Score | ||
| Total score | 9 (better) | 5 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 4 (better) | 1 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/S | 5.6× | 0.4× (better) |
| P/B | 5.1× (better) | 13.3× |
| EV/EBITDA | 76.6× | 7.2× (better) |
| P/FCF | – | 9.8× |
| FCF yield | −0.43% | 10.2% (better) |
| Fair value | $102.40 | – |
| Margin of safety | −208% | – |
| Growth | ||
| Revenue growth (TTM) | 4.5% (better) | 0.07% |
| Revenue growth, 5Y average | 6.3% (better) | 3.2% |
| Net income growth (TTM) | −103% | – |
| EPS growth (TTM) | −103% | – |
| Profitability | ||
| Gross margin | 32.1% (better) | 15.2% |
| Operating margin | −4.7% | – |
| Net margin | −0.38% (better) | −2.6% |
| FCF margin | −2.4% | 3.6% (better) |
| Return on equity | −0.32% (better) | −71.8% |
| Return on invested capital | −3.3% | – |
| Financial health | ||
| Debt / equity | 0.06 (better) | 24.73 |
| Net debt / EBITDA | −0.09 | 4.32 (better) |
| Interest coverage | −2.7× | – |
| Current ratio | 1.08 | 1.81 (better) |
| Altman Z-score | 2.60 (better) | 1.42 |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% | 2.6% (better) |
| Years of dividend growth | 16 (better) | 0 |
| Dividend growth, 5Y average | 6.6% (better) | −12.5% |
| Shareholder yield | 2.3% | 2.6% (better) |
| Ownership | ||
| Held by institutions | 91.3% | 90.2% |
| Held by insiders | 0.44% | 0.96% |
| Insider net buying, 12 months | −$20.8M | $489K (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 2.1% | 9.8% |
Go deeper
- APD stock overview
- APD income statement
- APD valuation and score
- CC stock overview
- CC income statement
- CC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.